Communication and proper preparation are necessary for a successful study.
The exciting world of stem cell therapy is the cutting edge of medical research. Here’s how it intersects with ophthalmology.
Researchers are exploring disease-modifying treatment options and not just symptomatic relief.
The eye is an ideal target for gene therapy.
Data may influence prescribing habits and formulary availability in future allergy seasons
Herantis Pharma’s Phase 2 Dry Eye study recruitment completed ahead of schedule
Clinical trial for the treatment of allergic rhinitis for 3E Therapeutics Corporation
Fields Medal winner Manjul Bhargava to give 2015 Commencement address, joining honorand Mark Abelson
Learning more about ocular allergy has revealed a host of potential allergic mediators for researchers to attack.